The Medacta International AMIStem-P Post-Marketing Surveillance Study

Inclusion Criteria

• •Patients with a disease (primary coxarthrosis, inflammatory arthritis of the hip, necrosis of the femoral head, etc.) requiring a total hip replacement
• •Patient eligible to receive an uncemented AMIStem-P femoral stem
• •Patient agreeing to comply with the study requirements
• •Patient willing to provide written informed consent
• •Patient affiliated to a social security system
• •Patients between 18 and 85 years old